Enhancement of glucose-induced insulin secretion in transgenic mice overexpressing human VIP gene in pancreatic beta cells. 1996

I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
Department of Biochemistry, Tohoku University School of Medicine, Miyagi, Japan.

Using transgenic mice technology, it has now become possible to test directly whether VIP and PHM-27 can enhance glucose-induced insulin secretion and reduce blood glucose in vivo. By microinjecting the entire human VIP gene ligated to the rat insulin II promoter, we have established a mouse model that overproduces VIP and PHM-27 in pancreatic beta cells. VIP was secreted from transgenic islets in a glucose-dependent manner. Analyses of these VIP-transgenic mice indicated that the transgene efficiently enhances glucose-induced insulin secretion and significantly reduces blood glucose as compared with control mice. The transgene also ameliorated glucose intolerance of 70% depancreatized mice. The present results suggest that somatic cell gene therapy directed to diabetic islets by human VIP/PHM-27 gene introduction may provide a means to improve the secretory function of the diabetic islets.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010451 Peptide PHI A 27-amino acid peptide with histidine at the N-terminal and isoleucine amide at the C-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems. Neuropeptide PHI 27,PHI Peptide,Peptide Histidine-Isoleucine,Peptide PHM,Human PHI,PHM Neuropeptide,PHM-27,Peptide HI,Peptide Histidine Methionine,Peptide PHI-27,Peptide-Histidine-Isoleucinamide,Porcine Intestinal Heptacosapeptide,Pro-Vasoactive Intestinal Peptide,Heptacosapeptide, Porcine Intestinal,Histidine Methionine, Peptide,Histidine-Isoleucine, Peptide,Intestinal Heptacosapeptide, Porcine,Intestinal Peptide, Pro-Vasoactive,Methionine, Peptide Histidine,Neuropeptide, PHM,PHI, Human,PHM, Peptide,Peptide Histidine Isoleucinamide,Peptide Histidine Isoleucine,Peptide PHI 27,Peptide, PHI,Peptide, Pro-Vasoactive Intestinal,Pro Vasoactive Intestinal Peptide
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
April 2004, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
September 1997, Diabetes,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
July 2000, Diabetologia,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
June 2005, Seikagaku. The Journal of Japanese Biochemical Society,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
August 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
January 2005, The Journal of clinical investigation,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
March 1994, Proceedings of the National Academy of Sciences of the United States of America,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
December 1996, Annals of the New York Academy of Sciences,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
October 1992, The Journal of biological chemistry,
I Kato, and Y Suzuki, and A Akabane, and H Yonekura, and O Tanaka, and H Kondo, and S Takasawa, and T Yoshimoto, and H Okamoto
June 2010, Experimental & molecular medicine,
Copied contents to your clipboard!